SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-19-010640
Filing Date
2019-05-13
Accepted
2019-05-13 17:52:44
Documents
1
Period of Report
2019-05-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 5901
  Complete submission text file 0001567619-19-010640.txt   7385
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Issuer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address HUDSON EXECUTIVE CAPITAL LP 570 LEXINGTON AVENUE, 35TH FLOOR NEW YORK NY 10022
Business Address
Braunstein Douglas L (Reporting) CIK: 0001495110 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36306 | Film No.: 19819752